Akso Health Group (AHG) Stock

HealthcareMedical Distribution Website

2 of the hedge funds AlphaScala tracks reported AHG in 13F filings for the quarter ended Jun 30, 2026; the largest reported position is Renaissance Technologies's at $105.7K.

Which hedge funds own AHG?

From 13F filings
FundShares HeldPosition ValueChange vs prior Q
Renaissance Technologies
Jim Simons (founder)
71K$105.7K-28%
Citadel
Ken Griffin
46K$68.6KNEW

13F holdings as of Jun 30, 2026

Explore all tracked funds →

AHG price chart

Powered by TradingView

What does Akso Health Group do?

Akso Health Group operates a social e-commerce mobile platform in China through its Xiaobai Maimai App, offering products such as food and beverages, wine, cosmetics, fashion and apparel, entertainment items, housewares, home appliances, and promotions at petrol stations. The company specializes in selling medical devices including defibrillators and anesthesia laryngoscopes, alongside healthcare equipment and product trading in China and the United States. It provides health treatment, consultancy support, marketing promotion, and technological services, as well as import and export activities. Akso Health Group holds equity interests in online medical providers in China, delivering consultations for initial diagnoses, follow-ups, and chronic disease management. The company integrates AI technologies, such as DeepSeek's models, to enhance its diagnosis systems and develop AI-powered medical assistants that analyze patient data, imaging, and tests for accurate recommendations. Operating in the healthcare sector with a focus on medical distribution, Akso Health Group combines e-commerce, device sales, and digital health services. Founded in 2014 and headquartered in Qingdao, China, it serves consumers and healthcare needs across multiple channels.

CEO
Ms. Yilin Wang
Employees
27
Ask about AHGAI research agent